{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:48:04Z","timestamp":1787500084150,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ymgme.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T21:52:47Z","timestamp":1617832367000},"page":"148-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Biomarkers for liver disease in urea cycle disorders"],"prefix":"10.1016","volume":"133","author":[{"given":"Sandesh C.S.","family":"Nagamani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Izem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Schady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Masand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin L.","family":"Shneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay C.","family":"Burrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.04.001_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0010","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132342","article-title":"Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency","volume":"5","author":"Burrage","year":"2020","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.ymgme.2021.04.001_bb0015","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jimd.12144","article-title":"Chronic liver involvement in urea cycle disorders","volume":"42","author":"Ranucci","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2021.04.001_bb0020","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10545-017-0088-5","article-title":"Liver involvement in urea cycle disorders: a review of the literature","volume":"40","author":"Bigot","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2021.04.001_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2014.08.001","article-title":"A longitudinal study of urea cycle disorders","volume":"113","author":"Batshaw","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2021.04.001_bb0030","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10545-015-9840-x","article-title":"The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype","volume":"38","author":"Kolker","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"10.1016\/j.ymgme.2021.04.001_bb0035","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10024-002-0109-7","article-title":"Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency","volume":"5","author":"Mori","year":"2002","journal-title":"Pediatr. Dev. Pathol."},{"issue":"7","key":"10.1016\/j.ymgme.2021.04.001_bb0040","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/humu.20498","article-title":"Argininosuccinate lyase deficiency: mutational spectrum in Italian patients and identification of a novel ASL pseudogene","volume":"28","author":"Trevisson","year":"2007","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.ymgme.2021.04.001_bb0045","first-page":"136","article-title":"Severe liver fibrosis in argininosuccinic aciduria","volume":"110","author":"Zimmermann","year":"1986","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"8","key":"10.1016\/j.ymgme.2021.04.001_bb0050","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1023\/A:1013960712516","article-title":"Liver transplantation in a case of argininaemia","volume":"24","author":"Santos Silva","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2021.04.001_bb0055","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00726-015-2032-z","article-title":"Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature","volume":"47","author":"Schlune","year":"2015","journal-title":"Amino Acids"},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MPG.0b013e3180ca8720","article-title":"Living related liver transplant in a patient with argininosuccinic aciduria and cirrhosis: metabolic follow-up","volume":"46","author":"Marble","year":"2008","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2021.04.001_bb0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.12659\/AOT.904580","article-title":"Polish experience with liver transplantation and post-transplant outcomes in children with urea cycle disorders","volume":"22","author":"Szymanska","year":"2017","journal-title":"Ann. Transplant."},{"issue":"2","key":"10.1016\/j.ymgme.2021.04.001_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.510260217","article-title":"Focal glycogenosis of the liver in disorders of ureagenesis: its occurrence and diagnostic significance","volume":"26","author":"Badizadegan","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2021.04.001_bb0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/1093526617697058","article-title":"Biopsy-proven hepatocellular carcinoma in a 53-year-old woman with arginase deficiency","volume":"20","author":"Koo","year":"2017","journal-title":"Pediatr. Dev. Pathol."},{"issue":"2","key":"10.1016\/j.ymgme.2021.04.001_bb0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymgme.2011.10.016","article-title":"Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency","volume":"105","author":"Wilson","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pediatrneurol.2012.06.012","article-title":"Arginase deficiency with new phenotype and a novel mutation: contemporary summary","volume":"47","author":"Tsang","year":"2012","journal-title":"Pediatr. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2021.04.001_bb0090","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10545-017-0022-x","article-title":"Expanding the phenotype in argininosuccinic aciduria: need for new therapies","volume":"40","author":"Baruteau","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2021.04.001_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2313791","article-title":"Hepatocellular adenoma in a patient with ornithine transcarbamylase deficiency","volume":"2019","author":"Cheng","year":"2019","journal-title":"Case Reports Hepatol."},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153358","article-title":"Frequency and pathophysiology of acute liver failure in ornithine transcarbamylase deficiency (OTCD)","volume":"11","author":"Laemmle","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0105","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jpeds.2013.12.024","article-title":"Significant hepatic involvement in patients with ornithine transcarbamylase deficiency","volume":"164","author":"Gallagher","year":"2014","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2021.04.001_bb0110","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s11011-018-0281-8","article-title":"Recurrent hepatic failure and status epilepticus: an uncommon presentation of hyperargininemia","volume":"33","author":"Yucel","year":"2018","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ymgme.2010.12.007","article-title":"Transient fulminant liver failure as an initial presentation in citrullinemia type I","volume":"102","author":"Faghfoury","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2021.04.001_bb0120","doi-asserted-by":"crossref","first-page":"S413","DOI":"10.1007\/s10545-010-9207-2","article-title":"Metabolic investigations prevent liver transplantation in two young children with citrullinemia type I","volume":"33","author":"de Groot","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2021.04.001_bb0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/lt.21297","article-title":"Liver transplantation for argininosuccinic aciduria: clinical, biochemical, and metabolic outcome","volume":"14","author":"Newnham","year":"2008","journal-title":"Liver Transpl."},{"issue":"2","key":"10.1016\/j.ymgme.2021.04.001_bb0130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0168-8278(03)00191-0","article-title":"Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease","volume":"39","author":"Colloredo","year":"2003","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1381\/0960892053723268","article-title":"Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies","volume":"15","author":"Janiec","year":"2005","journal-title":"Obes. Surg."},{"issue":"10","key":"10.1016\/j.ymgme.2021.04.001_bb0140","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.ymgme.2021.04.001_bb0145","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1111\/j.1572-0241.2002.05997.x","article-title":"Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C","volume":"97","author":"Myers","year":"2002","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ymgme.2021.04.001_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-5926-3-8","article-title":"Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C","volume":"3","author":"Poynard","year":"2004","journal-title":"Comp. Hepatol."},{"issue":"9262","key":"10.1016\/j.ymgme.2021.04.001_bb0155","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ymgme.2021.04.001_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.ymgme.2021.04.001_bb0165","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"issue":"13\u201314","key":"10.1016\/j.ymgme.2021.04.001_bb0170","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.clinbiochem.2013.04.001","article-title":"CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche and Siemens Clinical Chemistry Assays: direct validation using reference samples from the CALIPER cohort","volume":"46","author":"Estey","year":"2013","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.ymgme.2021.04.001_bb0175","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1373\/clinchem.2011.177741","article-title":"Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children","volume":"58","author":"Colantonio","year":"2012","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2021.04.001_bb0180","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ymgme.2021.04.001_bb0185","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ymgme.2021.04.001_bb0190","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1148\/radiol.2015150619","article-title":"Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement","volume":"276","author":"Barr","year":"2015","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ymgme.2021.04.001_bb0195","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/MPG.0000000000002320","article-title":"Normal liver stiffness values in children: a comparison of three different elastography methods","volume":"68","author":"Mjelle","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2021.04.001_bb0200","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpeds.2019.12.033","article-title":"Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease: interim results of a prospective observational case-controlled study","volume":"219","author":"Siegel","year":"2020","journal-title":"J. Pediatr."},{"issue":"6","key":"10.1016\/j.ymgme.2021.04.001_bb0205","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jimd.12100","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders: first revision","volume":"42","author":"Haberle","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgme.2021.04.001_bb0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2013.01.006","article-title":"Histopathological findings in livers of patients with urea cycle disorders","volume":"108","author":"Yaplito-Lee","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0215","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/ajg.2017.5","article-title":"Prevalence of nonalcoholic steatohepatitis-associated cirrhosis in the United States: an analysis of national health and nutrition examination survey data","volume":"112","author":"Kabbany","year":"2017","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0220","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2018.06.023","article-title":"Urea cycle dysregulation in non-alcoholic fatty liver disease","volume":"69","author":"De Chiara","year":"2018","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.ymgme.2021.04.001_bb0225","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2015.11.019","article-title":"Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension","volume":"64","author":"Jalan","year":"2016","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.ymgme.2021.04.001_bb0230","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ymgme.2012.09.016","article-title":"A randomized controlled trial to evaluate the effects of high-dose versus low-dose of arginine therapy on hepatic function tests in argininosuccinic aciduria","volume":"107","author":"Nagamani","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2021.04.001_bb0235","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/nm.2544","article-title":"Requirement of argininosuccinate lyase for systemic nitric oxide production","volume":"17","author":"Erez","year":"2011","journal-title":"Nat. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221006855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719221006855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:49:47Z","timestamp":1761090587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719221006855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1096719221006855"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.04.001","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers for liver disease in urea cycle disorders","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}